Overview of the Treatment of Allergic Rhinitis and Nonallergic Rhinopathy
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Allergic rhinitis (AR) and nonallergic rhinopathy (NAR) represent common nasal conditions affecting millions of individuals across the world. Although patients present with similar symptomatology, those with NAR are frequently affected only after childhood and present with a lack of other comorbid atopic disorders such as asthma, atopic dermatitis, and food allergies. Patients with pure NAR usually have no identifiable specific allergen sensitivity, whereas those with mixed (allergic and nonallergic) rhinitis are sensitized to aeroallergens in a manner that does not fully explain the duration or extent of their symptoms. This review presents the diverse options of currently available pharmacologic agents for the treatment of AR and NAR, including intranasal corticosteroids, H1-antihistamines, decongestants, cromolyn sodium, antileukotrienes, anticholinergics, capsaicin, anti-IgE, and intranasal saline, in addition to subcutaneous immunotherapy. Furthermore, treatment algorithms for AR and NAR are presented with a stepped-up, stepped-down scheme to aid the clinician in choosing appropriate therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729 · cited 19×
“Although a metaanalysis published in 2006 proposed that montelukast should be used as second-line therapy for the treatment of AR (95), the joint task force on practice parameters for allergy and immunology concluded that montelukast may be as effective as oral AHs, with the usual comparator being loratadine.”
BackgroundInfluentialSelf-citationThe diagnosis and management of rhinitis: An updated practice parameter
WALLACE, D., DYKEWICZ, M., BERNSTEIN, D., BLESSINGMOORE, J., COX, L., KHAN, D., LANG, D., NICKLAS, R., OPPENHEIMER, J., & PORTNOY, J. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.06.003 · Cited by 1,096 · cited 3×
“INS are the single most effective class of medications for AR and are thus recommended as first-line therapy by both national and international task forces for those with moderate-severe or persistent rhinitis(2, 3).”
BackgroundMöller, C., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Jacobsen, L., Koivikko, A., Koller, D. Y., Niggemann, B., Norberg, L. A., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121317 · Cited by 1,065
Jacobsen, L., Niggemann, B., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Koivikko, A., Norberg, L. A., Valovirta, E., Wahn, U., et al. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01451.x · Cited by 976
Weiner, J. M., Abramson, M. J., & Puy, R. M. (1998) · BMJ · doi:10.1136/bmj.317.7173.1624 · Cited by 527 · cited 15×
“Although a metaanalysis published in 2006 proposed that montelukast should be used as second-line therapy for the treatment of AR (95), the joint task force on practice parameters for allergy and immunology concluded that montelukast may be as effective as oral AHs, with the usual comparator being loratadine.”
BackgroundInfluentialEpidemiology of Physician-Diagnosed Allergic Rhinitis in Childhood
Wright, A. L., Holberg, C. J., Halonen, M., Martinez, F. D., Morgan, W., & Taussig, L. M. (1994) · Pediatrics · doi:10.1542/peds.94.6.895 · Cited by 441
Vignola, A. M., Humbert, M., Bousquet, J., Boulet, L., Hedgecock, S., Blogg, M., Fox, H., & Surrey, K. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00550.x · Cited by 405 · cited 1×
“Multiple randomized, double-blind, placebo-controlled studies have shown efficacy of omalizumab in seasonal (108, 109) and perennial AR (110, 111).”
BackgroundCasale, T. B. (2001) · JAMA · doi:10.1001/jama.286.23.2956 · Cited by 377
Cox, L., Platts-Mills, T. A. E., Finegold, I., Schwartz, L. B., Simons, F. E. R., & Wallace, D. V. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.032 · Cited by 295 · cited 1×
“Given its high cost, reports of anaphylaxis (112), and lack of oral or inhaled routes of administration, its role in the treatment of AR will likely remain limited.”
BackgroundWELSH, P. W., STRICKER, W. E., CHU, C.-P., NAESSENS, J. M., REESE, M. E., REED, C. E., & MARCOUX, J. P. (1987) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61882-5 · Cited by 246
Cited by
Histamine and H1-antihistamines: Celebrating a century of progress
Simons, F. E. R., & Simons, K. J. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.09.005 · Cited by 541
Rhinitis 2020: A practice parameter update
Dykewicz, M. S., Wallace, D. V., Amrol, D. J., Baroody, F. M., Bernstein, J. A., Craig, T. J., Dinakar, C., Ellis, A. K., Finegold, I., Golden, D. B. K., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.007 · Cited by 436
Self-citationPhenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report
Papadopoulos, N. G., Bernstein, J. A., Demoly, P., Dykewicz, M., Fokkens, W., Hellings, P. W., Peters, A. T., Rondon, C., Togias, A., & Cox, L. S. (2015) · Allergy · doi:10.1111/all.12573 · Cited by 182
“Intranasal antihistamines (IAI) antagonize H1 receptors, exert a local anti-inflammatory effect (21), are effective for nasal congestion (178), and have a rapid onset of action (179).”
BackgroundInfluentialWhen sneezing indicates the cell type
Gelardi, M., Quaranta, N., & Passalacqua, G. (2013) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21119 · Cited by 12
Metadata
- Authors
- Greiner, A. N., & Meltzer, E. O.
- Venue
- Proceedings of the American Thoracic Society
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03-01
- Volume
- 8
- Issue
- 1
- Pages
- 121-131
- ISSN
- 1546-3222 (ISSN-L)
- 1943-5665
- OpenAlex
- W2031826255
- Cited by
- 75
- References
- 17
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Overview of the Treatment of Allergic Rhinitis and Nonallergic Rhinopathy. https://app.cochat.ai/papers/10.1513/pats.201004-033rn
- The paper
- Greiner, A. N., & Meltzer, E. O. (2011). Overview of the Treatment of Allergic Rhinitis and Nonallergic Rhinopathy. Proceedings of the American Thoracic Society. https://doi.org/10.1513/pats.201004-033rn
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.